GBT Announces Participation at the 2018 Wedbush PacGrow Healthcare Conference

SOUTH SAN FRANCISCO, Calif. , Aug. 07, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will present at the 2018 Wedbush PacGrow Healthcare Conference in New York City on Tuesday, August 14 at 10:20 a.m. Eastern Time.

The presentation will be webcast live and available for replay from GBT’s website at www.gbt.com in the Investors section.

About GBTGBT is a clinical-stage biopharmaceutical company determined to discover, develop and deliver innovative treatments that provide hope to underserved patient communities. GBT is developing its lead product candidate, voxelotor, as an oral, once-daily therapy for sickle cell disease. To learn more, please visit www.gbt.com and follow the company on Twitter @GBT_news.

Contact Information:Myesha Lacy (investors)GBT650-351-4730[email protected]

Julie Normart (media)W2Opure415-946-1087[email protected]

Source: Global Blood Therapeutics, Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Americas Uranium Corp. Engages Venture Liquidity Providers Inc.
• Renewal by Andersen of Western Washington Surpasses 1,790 Google Reviews, Reinforcing Its Position as Tacoma, WA's Top-Rated Window Replacement Company
• eGenesis Announces Clinical Update in Ongoing Expanded Access Study of EGEN-2784 in Patients with Kidney Failure